The Genotype and Phenotype of Lymphangioleiomyomatosis

This study aims to differentiate between sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex-associated Lymphangioleiomyomatosis.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Sporadic Lymphangioleiomyomatosis Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Lymphangioleiomyomatosis Lymphangiomyoma Lymphatic Diseases Lymphoproliferative Disorders Neoplasm, Lymphatic Tissue Neoplasms Neoplasms by Histologic Type Neoplasms, Connective and Soft Tissue Perivascular Epithelioid Cell Neoplasms TSC-associated Lymphangioleiomyomatosis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

National Taiwan University Hospital

Taipei, Taiwan

Location status: Recruiting

Location contact

Yao-Wen Kuo, MD

CONTACT

[email protected]

0972-651-821

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age ≥ 18 y/o
Patient with Chest CT showed cystic lung disease, suspected Lymphangioleiomyomatosis

Exclusion criteria

age < 18 y/o

Treatment and study plan

Primary outcomes

The genotype and phenotype of lymphangioleiomyomatosis

Time frame: one month

Study contacts

Contact information is provided by the study sponsor or research team.

Yao-Wen Kuo

CONTACT

[email protected]

0972-651-821

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2027
Study completion: 2027
First posted: May 9, 2024
Registry last updated: May 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting